Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024

BEDFORD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it will participate in the UBS Virtual Opthalmology Day 2024: UBS Virtual Opthalmology Day 2024Fireside Chat Date: Wednesday, October 2, 2024Presentation Time: 3:00 PM ETOcular Pres ...